AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
90.07%
Total 13F principal
$327,627,940
Principal change
+$1,118,000
Total reported market value
$300,811,000
Number of holders
20
Value change
+$2,692,371
Number of buys
5
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q3 2020

As of 30 Sep 2020, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $327,627,940 in principal (par value) of the bond. The largest 10 bondholders included BlackRock Inc., HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, ANGELO GORDON & CO., L.P., Birch Grove Capital LP, WOLVERINE ASSET MANAGEMENT LLC, Context Partners Fund, L.P., Context Capital Management, LLC, Whitebox Advisors LLC, and AMERIPRISE FINANCIAL INC. This page lists 20 institutional bondholders reporting positions for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.